Anti-PD1/PDL1 induced psoriasis-Reference-Cited by-同舟云学术

Anti-PD1/PDL1 induced psoriasis

Published:2017-11 Issue:6 Volume:41 Page:407-412
ISSN:0147-0272
Container-title:Current Problems in Cancer
language:en
Short-container-title:Current Problems in Cancer

Author:

Voudouri Dimitra,Nikolaou Vasiliki.,Laschos Konstantinos,Charpidou Andriani,Soupos Nikolaos,Triantafyllopoulou Ioanna,Panoutsopoulou Ioanna,Aravantinos Gerasimos,Syrigos K.,Stratigos A.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference9 articles.

1. Characterisation and management of dermatologic adverse events to agents targeting the PD-1 receptor;Belum;Eur J Cancer,2016

2. Cutaneous adverse events (AEs) of anti-programmed cell death (PD)-1 therapy in patients with metastatic melanoma: a single—institution cohort;Hwang;J Am Acad Dermatol,2016

3. Anti-PD1 induced psoriasis: a study of 21 patients;Bonigen;J Eur Acad Dermatol Venereol,2017

4. Exacerbation of psoriasis vulgaris during nivolumab for oral mucosal melanoma;Kato;J Eur Acad Dermatol Venereol,2016

5. Development of PD-1/PD-L1 pathway in tumor immune microenvironment and treatment for non-small cell lung cancer;He;Sci Rep,2015

Cited by 99 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune Checkpoint Inhibitor-Induced Psoriasis;Dermatologic Clinics;2024-07

2. Advances in Foxp3+ regulatory T cells (Foxp3+ Treg) and key factors in digestive malignancies;Frontiers in Immunology;2024-06-11

3. Exploring the Dynamics of B Cell Subpopulations in Response to Immune Checkpoint Inhibitors: A Prospective Study;Applied Sciences;2024-06-07

4. Risk Factors for Psoriasis Flares: A Narrative Review;Psoriasis: Targets and Therapy;2024-05

5. A Case of Punctate Psoriasis Following Treatment with Cetuximab in a Patient with Metastatic Gastric Adenocarcinoma;Journal of Inflammation Research;2024-04